DrugPatentWatch Database Preview

CENTANY Drug Profile

Email this page to a colleague

« Back to Dashboard

When do Centany patents expire, and when can generic versions of Centany launch?

Centany is a drug marketed by Perrigo New York and is included in one NDA.

The generic ingredient in CENTANY is mupirocin. There are sixteen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the mupirocin profile page.

US ANDA Litigation and Generic Entry Outlook for Centany

A generic version of CENTANY was approved as mupirocin by PERRIGO ISRAEL on November 7^th, 2003.

Summary for CENTANY

US Patents:	0
Applicants:	1
NDAs:	1
Suppliers / Packagers:	2
Bulk Api Vendors:	64
Clinical Trials:	2
Patent Applications:	4,895
Formulation / Manufacturing:	see details
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for CENTANY
DailyMed Link:	CENTANY at DailyMed

Recent Clinical Trials for CENTANY

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
National Jewish Health	Phase 2
University of Texas Southwestern Medical Center	Phase 2
Cook Children's Medical Center	Phase 2

See all CENTANY clinical trials

Recent Litigation for CENTANY

Identify potential future generic entrants

District Court Litigation

Case Name	Date
Jetblue Airways Corporation v. Helferich Patent Licensing, LLC	2012-11-27
In Re: DigaComm LLC	2008-04-09
Plaintiff(s) v. Defendant(s)	2008-01-31

See all CENTANY litigation

Pharmacology for CENTANY

Drug Class	RNA Synthetase Inhibitor Antibacterial
Mechanism of Action	RNA Synthetase Inhibitors

Synonyms for CENTANY

(E)-(2S,3R,4R,5S)-5-((2S,3S,4S,5S)-2,3-Epoxy-5-hydroxy-4-methylhexyl)tetrahydro-3,4-dihydroxy-beta-methyl-2H-pyran-2-crotonic acid, ester with 9-hydroxynonanoic acid

115074-43-6

12650-69-0

1jzs

5,9-Anhydro-2,3,4,8-tetradeoxy-8-[[3-(2-hydroxy-1-methylpropyl)oxiranyl]methyl]-3-methyl-[2E,8[2S,3S(1S,2S)]]-L-talonon-2-enonic acid 8-carboxyoctyl ester

6-Chloro-2,4-dimethoxy pyrimidine

8-Carboxyoctyl (E)-4-(2S,3R,4R,5S)-5-((2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl)-3,4-dihydroxytetrahydro-2H-pyran-2-yl)-3-methylcrotonat

80558-54-9

9-(((E)-4-((2S,3R,4R,5S)-3,4-dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyl)oxy)nonanoic acid

9-((E)-4-((2S,3R,4R,5S)-3,4-dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)-tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyloxy)nonanoic acid

9-((E)-4-((2S,3R,4R,5S)-3,4-dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyloxy)nonanoic acid

9-((E)-4-{(2S,3R,4R,5S)-3,4-Dihydroxy-5-[(2S,3S)-3-((1S,2S)-2-hydroxy-1-methyl-propyl)-oxiranylmethyl]-tetrahydro-pyran-2-yl}-3-methyl-but-2-enoyloxy)-nonanoic acid

9-((E)-4-{(2S,3R,4R,5S)-3,4-Dihydroxy-5-[(2S,3S)-3-((1S,2S)-2-hydroxy-1-methyl-propyl)oxiranylmethyl]tetrahydro-pyran-2-yl}-3-methyl-but-2-enoyloxy)nonanoic acid calcium salt

9-((E)-4-{(2S,3R,4R,5S)-3,4-Dihydroxy-5-[(2S,3S)-3-((1S,2S)-2-hydroxy-1-methyl-propyl)oxiranylmethyl]tetrahydro-pyran-2-yl}-3-methyl-but-2-enoyloxy)nonanoic acid lithium salt

9-({(2E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-({(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl}methyl)tetrahydro-2H-pyran-2-yl]-3-methylbut-2-enoyl}oxy)nonanoic acid

9-(4-((2S,3R,4R,5S)-3,4-dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)-tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyloxy)nonanoic acid

9-(4-{3,4-Dihydroxy-5-[3-(2-hydroxy-1-methyl-propyl)-oxiranylmethyl]-tetrahydro-pyran-2-yl}-3-methyl-but-2-enoyloxy)-nonanoic acid (Mupirocin)

9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3- [(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl] oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acid

9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(1S,2S)-2-hydroxy-1-methyl-propyl]oxiran-2-yl]methyl]tetrahydropyran-2-yl]-3-methyl-but-2-enoyl]oxynonanoic acid

9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acid

9-{[(2E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-{[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl}oxan-2-yl]-3-methylbut-2-enoyl]oxy}nonanoic acid

AB0010371

AB01563109_01

AKOS015994756

AOB6353

AS-11580

Bactoderm

Bactroban

Bactroban (TN)

Bactroban Ointment

BDBM50290686

BIDD:GT0320

BRD-K15262564-001-06-9

BRL 4910A

BRL-4910A

C11758

C26H44O9

CAS-12650-69-0

CCG-213522

Centany (TN)

CHEBI:7025

CHEBI:94519

CHEMBL719

cid_446596

CPD000471888

D01076

D0GX863OA5

DB00410

DSSTox_CID_26438

DSSTox_GSID_46438

DSSTox_RID_81614

DTXSID0046438

HMS2234E20

HMS3259L05

HMS3712K03

HY-B0958

KS-5137

L-talo-Non-2-enonic acid, 5,9-anhydro-2,3,4,8-tetradeoxy-8-[[(2S,3S)-3-[(1S,2S)-2-hydroxy-1-methylpropyl]oxiranyl]methyl]-3-methyl-, 8-carboxyoctyl ester, (2E)-

LS-177887

M-8680

M2955

MFCD01711620

MFCD11977847

MINDHVHHQZYEEK-HBBNESRFSA-N

MLS001074711

MRC

Mupirocin

Mupirocin (USP/INN)

Mupirocin [USAN:USP:INN:BAN]

mupirocin calcium salt

mupirocin lithium salt

Mupirocin Neo-Sensitabs

Mupirocin, >=92% (HPLC), powder

Mupirocin, 14C-Labeled

Mupirocin, Antibiotic for Culture Media Use Only

Mupirocin, Pseudomonic Acid A

Mupirocin, United States Pharmacopeia (USP) Reference Standard

Mupirocin,(S)

Mupirocina

Mupirocina [Spanish]

Mupirocine

Mupirocine [French]

Mupirocinum

Mupirocinum [Latin]

NC00620

NCGC00164554-03

NCGC00164554-05

Nonanoic acid, 9-((3-methyl-1-oxo-4-(tetrahydro-3,4-dihydroxy-5-((3-(2-hydroxy-1-methylpropyl)oxiranyl)methyl)-2H-pyran-2-yl)-2-butenyl)oxy)-, (2S-(2alpha(E),3beta,4beta,5alpha(2R*,3R*(1R*,2R*))))-

NSC-759182

NSC759182

Pharmakon1600-01505706

Plasimine

Pseudomonic acid

Pseudomonic acid A

Pseudomonic acid A lithium salt

Q413578

S4297

SAM002589979

SBI-0206892.P001

SC-16672

SCHEMBL1027618

SCHEMBL3291

SMR000471888

SR-05000001947

SR-05000001947-1

SR-05000001947-2

Tox21_112183

trans-Pseudomonic acid

Turixin

UNII-D0GX863OA5

ZINC4102194

US Patents and Regulatory Information for CENTANY

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Perrigo New York	CENTANY	mupirocin	OINTMENT;TOPICAL	050788-001	Dec 4, 2002	BX	RX	No	No

Expired US Patents for CENTANY

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Perrigo New York	CENTANY	mupirocin	OINTMENT;TOPICAL	050788-001	Dec 4, 2002

International Patents for CENTANY

Country	Patent Number	Estimated Expiration
Israel	123143
Spain	2165723
Canada	2259764
European Patent Office	0933081
Germany	69900561